ArticleCureus2025
Gastric Myoelectric Activity in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Case-Control Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is increasingly recognized for its extrahepatic manifestations, including gastrointestinal dysfunctions such as gastroparesis. This case-control study aimed to determine whether patients with MASLD exhibit gastric myoelectric abnormalities using electrogastrography (EGG). Methodology A case-control study was conducted with 16 MASLD patients and 16 healthy controls. Participants underwent EGG recordings in fasting and post-prandial states, including a water load standard test (WLST). Demographic data and gastric myoelectric parameters were collected and analyzed using paired Student's t-tests and chi-square analysis. Results MASLD patients and controls were demographically well-matched. MASLD patients exhibited significantly higher water ingestion volumes during WLST (987.5 ± 222.5 mL vs. 656.3 ± 405.7 mL; p = 0.002), suggesting altered gastric accommodation. Trends toward hyponormal 3 cpm gastric myoelectric activity were observed in MASLD patients, though not statistically significant. Dysfunctional patterns related to interstitial cells of Cajal and antral pacemaker dysfunction were similarly distributed across both groups. Conclusions MASLD is associated with impaired gastric accommodation and possible myoelectric abnormalities, supporting its role as a multisystem disorder with gastrointestinal involvement. EGG may offer objective insights into gastric dysfunction in MASLD. Further large-scale studies are warranted to confirm these findings and integrate advanced motility testing.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.